Invesco India Contra Fund
The scheme seeks to generate capital appreciation by investing predominantly in Equity and Equity Related Instruments through contrarian investing.
Growthvine rating: 5/5 — ranked #1 of 5 in category.
Fund basics
| Category | Equity: Contra |
|---|
| NAV | ₹139.20 (as of 2026-11-13) |
|---|
| AUM | ₹19,229 Cr |
|---|
| Expense ratio | 1.42% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Taher Badshah |
|---|
| Exit load | For units in excess of 10% of the investment, 1% will be charged for redemption within 365 days |
|---|
Performance & risk
| 5-year annualised return | 10.48% |
|---|
| Sharpe ratio | 0.49 |
|---|
| Standard deviation | 16.39% |
|---|
| Max drawdown | −58.14% |
|---|
| Alpha | 2.84 |
|---|
| Beta | 1.02 |
|---|
Over 5 years, captured 104.1% of Nifty 500's upside and 95.8% of its downside.
Market cap allocation
| Large cap | 56.6% |
|---|
| Mid cap | 20.5% |
|---|
| Small cap | 22.9% |
|---|
Concentration
| Top 5 holdings | 20.3% |
|---|
| Top 10 holdings | 32.0% |
|---|
| Total holdings | 80 |
|---|
| Index overlap | 36.9% |
|---|
| Active share | 63.1% |
|---|
Top holdings
- ICICI Bank Ltd. — 6.8%
- Larsen & Toubro Limited — 4.7%
- State Bank Of India — 3.3%
- Mahindra & Mahindra Ltd. — 2.8%
- Bharti Airtel Ltd. — 2.7%
- Infosys Ltd — 2.6%
- Cholamandalam Investment and Finance Company Ltd — 2.4%
- COFORGE LIMITED — 2.3%
- Federal Bank Ltd. — 2.3%
- Apollo Hospitals Enterprises Ltd. — 2.1%
Top sectors
- Banking & Financial — 26.0%
- Software & Services — 9.5%
- Retail — 8.2%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 0.7% | — | — |
| 2025 | 3.1% | — | — |
| 2024 | 30.1% | — | — |
| 2023 | 28.8% | — | — |
| 2022 | 3.8% | — | — |